Developed catatonia with rhabdomyolysis and exacerbated cardiac failure upon switching from
clozapine to olanzapine owing to cardiomyopathy during clozapine medication - A case report …

Part I of this clinical report (http://www. pediatrics. org/cgi/doi/10.1542/peds. 2016-1570)
discusses the common clinical issues that may be encountered in caring for children and …

Increased interest in the demarcation of catatonia from other conditions such as
schizophrenia and autism is shown in the new DSM-5 category Catatonia Not Elsewhere …

The increased research activity aiming at improved delivery of pharmaceutical molecules
indicates the expansion of the field. An efficient therapeutic delivery approach is based on …

Objective Parkinson's disease (PD) is a progressive neurodegenerative disease. As the
severity of disease worsens, patients have lower tolerance for treatments and occasionally …

Purpose/Background: Neuroleptic malignant syndrome (NMS) has been described with
most antipsychotics, most commonly first generation. Clozapine has also been associated …

BACKGROUND: Amantadine, an aliphatic primary amine with complex actions on
neurotransmitter systems in the basal ganglia, is approved for treating Parkinson's disease …

Neuroleptic malignant syndrome (NMS) is a rare, life-threatening, idiosyncratic adverse
reaction to antipsychotic drugs. Despite the increasing rates in the prescription of …

A movement disorder emergency is an acute or sub-acutely evolving neurological illness
predominated by a primary movement disorder. Although Parkinson's disease (PD) is a …

Abstract Neuroleptic Malignant Syndrome (NMS) is an idiosyncratic and potentially life-
threatening reaction to neuroleptic drugs. Lithium is a first-line mood stabilizer used in the …